| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |